- £100.14m
- £79.20m
- $114.35m
- 94
- 69
- 77
- 95
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 92.3 | 63.8 | 87.1 | 120 | 114 |
Cost of Revenue | |||||
Gross Profit | 32.1 | 20.1 | 25.9 | 38.6 | 41.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 82.8 | 65.6 | 82.1 | 111 | 102 |
Operating Profit | 9.55 | -1.85 | 5.08 | 8.93 | 12.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 9.42 | -2 | 4.92 | 8.8 | 12.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.32 | -2.88 | 4 | 11.1 | 10.9 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8.32 | -2.96 | 3.56 | 11 | 10.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.32 | -2.96 | 3.56 | 11 | 10.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.129 | -0.027 | 0.051 | 0.173 | 0.176 |
Dividends per Share |